Eli Lilly’s obesity pill is less effective than Novo Nordisk’s, pivotal data suggest

Eli Lilly’s GLP-1 pill allowed obese patients to lose up to 11.2% of their body weight after 72 weeks of treatment, the company said Thursday. This is lower than the benchmark ...